* Disclaimer:  Our products and technologies are currently not available for clinical use. FDA or other regulatory agencies have not evaluated the statements on this website regarding our products and technologies. 

Our Pipeline


Developing a diversified product pipeline for integrated diagnostic, therapeutic and regenerative medicine. 


Theragnostic Technologies is actively pursuing strategies to develop and expand its exciting product portfolio. The company has a robust product pipeline, with multiple research, preclinical and preclinical IND (Investigational New Drug) candidates in development.